C. Ola Landgren, M.D. Chief of the Myeloma Service in the Division of Hematologic Oncology at Memorial Sloan Kettering Cancer Center Discusses Should MRD Negativity Be The Goal For Every Patient at Lymphoma & Myeloma on October 18, 2018.
Should MRD Negativity Be The Goal For Every Patient
